This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (160)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Carlos A. Pellegrini, MD; Christopher F. Heck, MD; Steven Raper, MD; Lawrence W. Way, MD

Arch Surg. 1989;124(7):778-781.

Abstract
• We examined the course of 51 consecutive patients who underwent pancreaticoduodenectomies between 1979 and 1987. Fifteen patients (30%) had a traditional pancreaticoduodenectomy and 36 (70%) had a pylorus-preserving procedure. Operative blood loss, resumption of oral intake, and time to discharge from the hospital were not different for the two operations. One patient (2%) died of complications of the operation, and 14 patients (27%) had nonlethal intra-abdominal complications. Two patients required reoperation: 1 had a hemoperitoneum and 1 had a breakdown of a choledochoenterostomy. Of the patients undergoing pancreaticoduodenectomy for cancer, 26 (74%) of 35 survived 1 year, 9 (47%) of 19 survived 3 years, and 3 (33%) of 10 patients survived 5 or more years postoperatively. Our data showed that (1) on a service where a large number of these operations is performed, the mortality rate of patients who have undergone a pancreaticoduodenectomy is substantially lower than in the past and that (2) the main reasons for these improved results are greater experience of a few surgeons who perform the procedure regularly and the availability of computed tomographic scans and skilled interventional radiologists, which allows postoperative infection and pancreatic fistulas to be controlled. Although pancreaticoduodenectomy is only palliative in most patients with cancer, it provides the best palliation and the only chance of cure, and the procedure can be recommended when performed in tertiary care centers that possess these elements of success.

(Arch Surg. 1989;124:778-781)

Author Affiliations
From the Surgical Service, Veterans Administration Medical Center, and the Department of Surgery, University of California, San Francisco.

Footnotes
Accepted for publication February 28, 1989.

Read before the 96th Annual Meeting of the Western Surgical Association, San Diego, Calif, November 14, 1988.

Reprint requests to Surgical Service (112), Veterans Administration Medical Center, 4150 Clement St, San Francisco, CA 94121 (Dr Way).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Complications after Pancreatoduodenectomy: Imaging and Imaging-guided Interventional Procedures
Gervais et al.
RadioGraphics 2001;21:673-690.
ABSTRACT | FULL TEXT  

What Prognostic Factors Are Important in Duodenal Adenocarcinoma?
Bakaeen et al.
Arch Surg 2000;135:635-642.
ABSTRACT | FULL TEXT  

Impact of Hospital Volume on Operative Mortality for Major Cancer Surgery
Begg et al.
JAMA 1998;280:1747-1751.
ABSTRACT | FULL TEXT  

Risk Analysis of Pancreatic Fistula After Pancreatic Head Resection
Sato et al.
Arch Surg 1998;133:1094-1098.
ABSTRACT | FULL TEXT  

Coil Embolization of Bleeding Visceral Pseudoaneurysms Following Pancreatectomy: The Importance of Early Angiography
Sato et al.
Arch Surg 1998;133:1099-1102.
ABSTRACT | FULL TEXT  

Standards for Pancreatic Resection in the 1990s
Castillo et al.
Arch Surg 1995;130:295-300.
ABSTRACT  

Preoperative Chemoradiation and Pancreaticoduodenectomy for Adenocarcinoma of the Pancreas
Evans et al.
Arch Surg 1992;127:1335-1339.
ABSTRACT  

Complications Following Pancreaticoduodenectomy: Current Management
Miedema et al.
Arch Surg 1992;127:945-950.
ABSTRACT  

Arterial Hemorrhage After Pancreatoduodenectomy: The 'Sentinel Bleed'
Brodsky and Turnbull
Arch Surg 1991;126:1037-1040.
ABSTRACT